Literature DB >> 3797955

Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor.

T Jonsson, J A Arnason, H Valdimarsson.   

Abstract

A new enzyme-linked immunosorbent assay (ELISA) screening test for total rheumatoid factor (RF) activity is described. Rabbit IgG was used as antigen and enzyme-conjugated monoclonal anti-kappa antibody as third layer. Of 183 samples measured for RF isotype levels, 60 were found to have one or more raised. In terms of raised isotypes the ELISA screening test had a sensitivity of 97% (58/60) while the Rheumaton had a sensitivity of only 75% (45/60). Nearly all discordant false-negative samples had only one RF isotype raised. The ELISA test gave 29% (53/183) and the Rheumaton 34% (63/183) false-positive results. Thus the ELISA test was more specific and sensitive for the detection of raised single RF isotypes than the Rheumaton and Rose-Waaler tests. Moreover, approximately 30% of RA patients were seronegative according to the conventional RF tests but only 8% in the new ELISA system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3797955     DOI: 10.1007/bf00541367

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Characterization and measurement of anti-IgG antibodies in human sera by radioimmunoassay (RIA).

Authors:  J Yamagata; E V Barnett; D W Knutson; H Nasu; D Chia
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents.

Authors:  A Tarkowski; L M Bjursten; L A Nilsson; H Nygren
Journal:  J Immunol Methods       Date:  1983-03-11       Impact factor: 2.303

3.  ELISA for rheumatoid factor.

Authors:  F T Willems; C C Klaasen de Kort
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

4.  Quantitation of rheumatoid factor by laser nephelometry.

Authors:  P J Roberts-Thomson; R M Wernick; M Ziff
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

5.  Laboratory diagnosis of rheumatoid arthritis: a solid phase radioassay for IgG and IgM antiglobulins.

Authors:  L J Nineham; F C Hay; I M Roitt
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

6.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

7.  Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors.

Authors:  I Teitsson; H Valdimarsson
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

8.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

9.  Precipitation of 125I-labelled IgG aggregates by factors in sera of healthy individuals and of patients with rheumatoid arthritis.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

10.  Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.

Authors:  I Teitsson; R H Withrington; M H Seifert; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

View more
  8 in total

1.  Immunological studies in the hyper-immunoglobulin D syndrome.

Authors:  A Haraldsson; C M Weemaes; A W De Boer; J A Bakkeren; G B Stoelinga
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

2.  Population study of the importance of rheumatoid factor isotypes in adults.

Authors:  T Jónsson; J Thorsteinsson; A Kolbeinsson; E Jónasdóttir; N Sigfússon; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

3.  Relation between bone erosions and rheumatoid factor isotypes.

Authors:  J A Arnason; T Jónsson; A Brekkan; K Sigurjónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

4.  Clinical implications of IgA rheumatoid factor subclasses.

Authors:  T Jónsson; H Thorsteinsson; S Arinbjarnarson; J Thorsteinsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

5.  Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Authors:  I Vallbracht; J Rieber; M Oppermann; F Förger; U Siebert; K Helmke
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

6.  Clinical significance of rheumatoid factor isotypes in seropositive arthritis.

Authors:  T Jónsson; H Valdimarsson
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

7.  Potential Use of Plectranthus amboinicus in the Treatment of Rheumatoid Arthritis.

Authors:  Jia-Ming Chang; Chun-Ming Cheng; Le-Mei Hung; Yuh-Shan Chung; Rey-Yuh Wu
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-23       Impact factor: 2.629

8.  Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.

Authors:  Johanna E Gehin; Rolf A Klaasen; Ellen S Norli; David J Warren; Silje W Syversen; Guro L Goll; Trine Bjøro; Tore K Kvien; Maria D Mjaavatten; Nils Bolstad
Journal:  Rheumatol Int       Date:  2021-05-04       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.